High blood pressure, or hypertension, is a leading global health challenge that significantly increases the risk of stroke, coronary artery disease, heart failure, and chronic kidney disease [3]. Globally, the number of individuals living with hypertension has risen substantially over recent decades, making effective diagnosis and management critical for public health [3]. Despite the availability of diagnostic tools and therapies, poor blood pressure control remains common, highlighting the ongoing need for optimized, evidence-based management strategies [1].
Understanding the Scope and Impact of Hypertension
Hypertension is widely recognized as the primary remediable risk factor for cardiovascular disease [2]. It affects more than 1 billion people worldwide and contributes to millions of preventable deaths each year [2]. Untreated or poorly controlled elevated blood pressure initiates a cardiovascular disease continuum, which can progress from structural and functional impairment of the circulatory system to severe outcomes like myocardial infarction, stroke, and cardiovascular death [7]. Public health initiatives continue to emphasize early detection and consistent monitoring to mitigate these long-term risks [2].
Standardized Care and Patient Empowerment
To improve blood pressure control on a broader scale, healthcare systems increasingly rely on standardized treatment protocols and coordinated care models [2]. These approaches often include:
- Using a core set of proven antihypertensive medications to increase availability and affordability [2].
- Implementing registries for cohort monitoring and treatment evaluation [2].
- Fostering patient empowerment and education regarding self-monitoring [2].
- Employing team-based care models to streamline clinical workflows and patient support [2].
Such health systems-strengthening approaches aim to address gaps in treatment, particularly in under-resourced regions [2].
Managing Complex Cases and Resistant Hypertension
While standard lifestyle modifications and conventional pharmacotherapy successfully lower blood pressure for many patients, some individuals experience treatment-resistant hypertension [3]. Resistant hypertension is generally defined as office blood pressure remaining at or above 140/90 mmHg despite the concurrent use of at least three different classes of antihypertensive agents—including a diuretic—at maximally tolerated doses, or the requirement of four or more medications regardless of blood pressure level [3]. For patients with difficult-to-control blood pressure, referral to specialized centers helps evaluate global cardiovascular risk profiles and screen for hypertension-mediated organ damage [6].
Innovative Device-Based Treatment Options
For individuals who do not achieve adequate control through medications alone, innovative device-based therapies offer new therapeutic pathways [3]. These interventions primarily target the autonomic nervous system to help regulate blood pressure [3]. Notable techniques currently studied and integrated into clinical development include:
- Renal denervation, which targets nerves surrounding the renal arteries [3].
- Carotid baroreceptor activation therapy to influence autonomic signaling [3].
- Carotid body ablation procedures [3].
These evolving strategies aim to provide additional support for patients whose hypertension is resistant to standard pharmacological approaches [3].
Addressing Conmeting Conditions Like Orthostatic Hypotension
Blood pressure management must also account for co-existing clinical conditions, such as orthostatic hypotension (OH) [4]. Hypertension and OH frequently occur together, driven by complex autonomic nervous system interactions [4]. While physiological reflexes normally prevent sudden drops or spikes in blood pressure during postural changes, autonomic dysfunction can complicate treatment goals [4]. Management strategies in these scenarios require careful clinical evaluation to balance the prevention of low-blood-pressure events—such as falls and syncopal episodes—with the control of high-blood-pressure risks like stroke and heart disease [4].
Sources
- 1. Optimizing hypertension treatment: Evidence-based approaches and new drugs.
- 2. Improved Blood Pressure Control to Reduce Cardiovascular Disease Morbidity and Mortality: The Standardized Hypertension Treatment and Prevention Project.
- 3. Innovative Device-Based Treatments for Hypertension.
- 4. A Review of Clinical Trial and Meta-Analyses of BP Treatment Strategies for Patients with Orthostatic Hypotension: Blood Pressure Management in Patients with Hypertension and Orthostatic Hypotension.
- 5. Current Trends of Hypertension Treatment in the United States.
- 6. Hypertension Treatment with Angiotensin Receptor Blockers and Other Antihypertensive Agents: A Real-World Registry from a High-Volume Specialized Center Over TwoDecades.
- 7. Benefits Beyond Hypertension Control: Current and Evolving Treatment Strategies for Prevention of Cardiovascular Diseases.
- 8. Therapeutic Approach to Heart Failure Management: Insight from Clinical Trials.